{
    "ticker": "BCLI",
    "name": "Brainstorm Cell Therapeutics Inc.",
    "description": "Brainstorm Cell Therapeutics Inc. is a leading biotechnology company focused on the development and commercialization of innovative therapies for neurodegenerative diseases. Founded in 2004, Brainstorm has pioneered the use of its proprietary NurOwn\u00ae platform, which utilizes a patient's own mesenchymal stem cells to create therapeutic cells capable of secreting neuroprotective factors. This unique approach aims to address unmet medical needs in conditions such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The company is dedicated to advancing its clinical research and has shown promising results in its trials, positioning itself as a key player in the field of regenerative medicine. Brainstorm is committed to enhancing the quality of life for patients suffering from debilitating neurological disorders and strives to bring innovative solutions to the market. With a strong focus on scientific excellence and patient-centric approaches, Brainstorm aims to lead the way in the development of transformative therapies that can change the landscape of neurodegenerative diseases.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2004",
    "website": "https://www.brainstorm-cell.com",
    "ceo": "Chaim Lebovits",
    "social_media": {
        "twitter": "https://twitter.com/BrainstormCell",
        "linkedin": "https://www.linkedin.com/company/brainstorm-cell-therapeutics/"
    },
    "investor_relations": "https://ir.brainstorm-cell.com",
    "key_executives": [
        {
            "name": "Chaim Lebovits",
            "position": "CEO"
        },
        {
            "name": "Ron Cohen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "NurOwn\u00ae"
            ]
        }
    ],
    "seo": {
        "meta_title": "Brainstorm Cell Therapeutics Inc. | Innovating Neurodegenerative Disease Therapies",
        "meta_description": "Explore Brainstorm Cell Therapeutics Inc., a leader in biotechnology dedicated to developing groundbreaking treatments for neurodegenerative diseases using its proprietary NurOwn\u00ae technology.",
        "keywords": [
            "Brainstorm Cell Therapeutics",
            "Neurodegenerative Diseases",
            "ALS",
            "Biotechnology",
            "Stem Cell Therapy",
            "NurOwn"
        ]
    },
    "faq": [
        {
            "question": "What is Brainstorm Cell Therapeutics known for?",
            "answer": "Brainstorm Cell Therapeutics is known for its innovative therapies for neurodegenerative diseases, particularly using its NurOwn\u00ae platform."
        },
        {
            "question": "Who is the CEO of Brainstorm Cell Therapeutics?",
            "answer": "Chaim Lebovits is the CEO of Brainstorm Cell Therapeutics Inc."
        },
        {
            "question": "Where is Brainstorm Cell Therapeutics headquartered?",
            "answer": "Brainstorm Cell Therapeutics is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Brainstorm's main products?",
            "answer": "Brainstorm's main product is NurOwn\u00ae, a stem cell therapy for neurodegenerative diseases."
        },
        {
            "question": "When was Brainstorm Cell Therapeutics founded?",
            "answer": "Brainstorm Cell Therapeutics was founded in 2004."
        }
    ],
    "competitors": [
        "AAPL",
        "AMGN",
        "BMY",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRNA",
        "GILD"
    ]
}